Dimension Therapeutics appoints committee members
This article was originally published in Scrip
Executive Summary
Dimension Therapeutics, a rare disease company advancing liver-directed treatments for diverse genetic disorders, has expanded its scientific advisory committee (SAC) with the appointments of Dr Ian Alexander, of the Sydney Children's Hospitals Network, and Dr Nicola Longo, of the University of Utah.